Nagi Bioscience passed stage 2 of Venture Kick! Let’s continue on our way: stage 3, here we come!
We are glad to announce that Nagi is among the 66 high-impact startups that will join the final stage of the MassChallenge acceleration program. Our startup will benefit from world-class mentorship, programming, and resources during for improving our business case. The accelerator program will start in June and culminate on October 30th at the MassChallenge SwitzerlandRead more about Nagi Bioscience is part of the 2018 MassChallenge Accelerator Program[…]
Our CEO Laurent Mouchiroud received the prestigious PERL (Prix Entreprendre Région Lausanne) Biotech Award 2018 during a ceremony held at the Theatre de Beaulieu in Lausanne. Each year, the PERL jury, made up of academic, economic and media representatives, is responsible for selecting and nominate the laureates. These laureates will benefit, before and after the prize-givingRead more about Nagi Bioscience won the PERL Biotech Award 2018[…]
Every year, 10 Swiss-based entrepreneurs with international high potential are selected by venturelab for the Swiss National Startup Team. The members of this team, the venture leaders, win a week entrepreneurial and business development training based in the Boston, US. In the context of the program, he is going to pitch at the Startup ChampionsRead more about Matteo was selected for Venture Leaders Life Sciences 2018[…]
Great news: Nagi Bioscience passed stage 1 of Venture Kick! On the way for stage 2 now! Venture Kick was launched in 2007 with the vision to double the number of spin-offs at Swiss universities, to accelerate the time-to-market and to raise the attractiveness of these young companies to professional investors and industry partners. Selected members fromRead more about Nagi Bioscience passed Venture Kick Stage I[…]
We are glad and very proud to be among the TOP50 start-up in which to invest in 2018 selected by the prestigious swiss economic newspaper Bilan. Every year, the magazine Bilan selects 50 of the most promising StartUps in Switzerland. A jury made up of innovation professionals selects Swiss nuggets, in fields as varied as fintech, biotech,Read more about Nagi Bioscience listed in Bilan’s top 50 Swiss start-up companies![…]
From tomorrow morning till Friday evening, Nagi Bioscience will attend the Hello Tomorrow Summit in Paris as one of the World’s TOP500 Deep-Tech Startups. We are glad to be one of the startups selected for a showcase of our technology during this event. Come to visit us at booth #14 on Friday morning and seeRead more about Nagi Bioscience at the Hello Tomorrow Summit in Paris[…]
We are delighted to announce that Nagi Bioscience has been chosen by Hello Tomorrow as one of the world’s TOP 500 deep-tech startups! Hello Tomorrow is a global not-for-profit organization created by deep tech entrepreneurs, with a mission to empower and connect the most promising deep-tech entreprises across the globe to accelerate the transfer of breakthrough technologies into real worldRead more about We made it to the TOP 500 in the Hello Tomorrow Global Challenge![…]
Our Business Plan was awarded as TOP 10, among 108 submitted projects! »Venture» is Switzerland’s premier startup competition, initiative of ETH Zurich, EPF Lausanne, Knecht Holding, the innovation promotion agency CTI and McKinsey & Company, Switzerland.
This prestigious prize is given annually by the “E. Naef Foundation for in vitro research” (FENRIV), established in 1998. The foundation assists researchers investigating scientific means for restricting the use of vivisection and generally promotes in vitro research. Our team has been awarded for its work on the development of a novel in vitro technologyRead more about Nagi Bioscience wins the Egon Naef Award 2017[…]